viral vectors
| 4 min read
Transgene expands a duck-cell-line license as its personalized cancer vaccines advance deeper into the clinic
| 3 min read
A new platform combines engineered viral vectors with the brain's glymphatic system to improve gene delivery to glial cells implicated in multiple neurological disorders.
| 5 min read
The field's foundational biology is no longer the limiting factor. What comes next depends on whether the industry can build the manufacturing, commercial, and clinical infrastructure to match what the science already knows how to do.
| 5 min read
ReiThera’s gorilla-derived adenovirus vector is helping advance vaccines and therapies for COVID-19, HIV, Ebola, and even cancer.
| 4 min read
At the Advanced Therapies conference, industry leaders showcased how in vivo CAR T cell and gene delivery innovations could transform accessibility and clinical outcomes.
| 5 min read
Ireland’s model for advanced therapy manufacturing integrates academic research, workforce development, and regulatory bodies to streamline the production of complex biologics.
| 5 min read
Researchers created an improved method for assays that detect viral vectors in a patient’s blood or urine. It’s used to ensure that bystanders will not be exposed.
| 1 min read
Since their discovery in the 1890s, viruses have intrigued scientists as potential cancer-killing agents.
| 5 min read
An understudied passageway linking the inner ear and the brain in mice offers a potential delivery route for restoring hearing in humans.
Available on Demand
Scientists tackle AAV gene therapy hurdles, from enhancing efficiency to managing immunogenicity to improve AAV gene therapy efficacy and safety.
Page 1 of 1 - 10 Total Items
